216 related articles for article (PubMed ID: 25078909)
1. Cryptic and rare Aspergillus species in Brazil: prevalence in clinical samples and in vitro susceptibility to triazoles.
Negri CE; Gonçalves SS; Xafranski H; Bergamasco MD; Aquino VR; Castro PT; Colombo AL
J Clin Microbiol; 2014 Oct; 52(10):3633-40. PubMed ID: 25078909
[TBL] [Abstract][Full Text] [Related]
2. Multilocus Phylogeny and Antifungal Susceptibility of Aspergillus Section Circumdati from Clinical Samples and Description of A. pseudosclerotiorum sp. nov.
Siqueira JP; Sutton DA; Gené J; García D; Wiederhold N; Peterson SW; Guarro J
J Clin Microbiol; 2017 Mar; 55(3):947-958. PubMed ID: 28053212
[TBL] [Abstract][Full Text] [Related]
3. Characterization of clinical strains of Aspergillus terreus complex: molecular identification and antifungal susceptibility to azoles and amphotericin B.
Escribano P; Peláez T; Recio S; Bouza E; Guinea J
Clin Microbiol Infect; 2012 Feb; 18(2):E24-6. PubMed ID: 22128886
[TBL] [Abstract][Full Text] [Related]
4. In Vitro Activities of Five Antifungal Drugs Against Opportunistic Agents of Aspergillus Nigri Complex.
Badali H; Fakhim H; Zarei F; Nabili M; Vaezi A; Poorzad N; Dolatabadi S; Mirhendi H
Mycopathologia; 2016 Apr; 181(3-4):235-40. PubMed ID: 26615417
[TBL] [Abstract][Full Text] [Related]
5. Susceptibility Testing of Common and Uncommon Aspergillus Species against Posaconazole and Other Mold-Active Antifungal Azoles Using the Sensititre Method.
Mello E; Posteraro B; Vella A; De Carolis E; Torelli R; D'Inzeo T; Verweij PE; Sanguinetti M
Antimicrob Agents Chemother; 2017 Jun; 61(6):. PubMed ID: 28416538
[TBL] [Abstract][Full Text] [Related]
6. In vitro activity of nine antifungal agents against clinical isolates of Aspergillus calidoustus.
Alastruey-Izquierdo A; Cuesta I; Houbraken J; Cuenca-Estrella M; Monzón A; Rodriguez-Tudela JL
Med Mycol; 2010 Feb; 48(1):97-102. PubMed ID: 19296366
[TBL] [Abstract][Full Text] [Related]
7. Comparison of the Sensititre YeastOne and CLSI M38-A2 Microdilution Methods in Determining the Activity of Amphotericin B, Itraconazole, Voriconazole, and Posaconazole against Aspergillus Species.
Wang HC; Hsieh MI; Choi PC; Wu CJ
J Clin Microbiol; 2018 Oct; 56(10):. PubMed ID: 30093391
[TBL] [Abstract][Full Text] [Related]
8. Antifungal susceptibilities to amphotericin B, triazoles and echinocandins of 77 clinical isolates of cryptic Aspergillus species in multicenter surveillance in Korea.
Won EJ; Shin JH; Kim SH; Choi MJ; Byun SA; Kim MN; Lee WG; Lee K; Uh Y; Shin MG; Suh SP
Med Mycol; 2018 Jun; 56(4):501-505. PubMed ID: 28992138
[TBL] [Abstract][Full Text] [Related]
9. Identification and in vitro antifungal susceptibility of causative agents of onychomycosis due to Aspergillus species in Mashhad, Iran.
Xu X; Naseri A; Houbraken J; Akbari F; Wang X; Zhao R; Zhang H; Najafzadeh MJ; Deng S
Sci Rep; 2021 Mar; 11(1):6808. PubMed ID: 33762586
[TBL] [Abstract][Full Text] [Related]
10. Aspergillus citrinoterreus, a new species of section Terrei isolated from samples of patients with nonhematological predisposing conditions.
Guinea J; Sandoval-Denis M; Escribano P; Peláez T; Guarro J; Bouza E
J Clin Microbiol; 2015 Feb; 53(2):611-7. PubMed ID: 25502530
[TBL] [Abstract][Full Text] [Related]
11. Molecular identification, phylogenetic analysis and antifungal susceptibility patterns of Aspergillusnidulans complex and Aspergillusterreus complex isolated from clinical specimens.
Mohamadnia A; Salehi Z; Namvar Z; Tabarsi P; Pourabdollah-Toutkaboni M; Rezaie S; Marjani M; Moniri A; Abtahian Z; Mahdaviani SA; Mortezaee V; Askari E; Sharifynia S
J Mycol Med; 2020 Sep; 30(3):101004. PubMed ID: 32534826
[TBL] [Abstract][Full Text] [Related]
12. Antifungal activities of posaconazole, ravuconazole, and voriconazole compared to those of itraconazole and amphotericin B against 239 clinical isolates of Aspergillus spp. and other filamentous fungi: report from SENTRY Antimicrobial Surveillance Program, 2000.
Pfaller MA; Messer SA; Hollis RJ; Jones RN;
Antimicrob Agents Chemother; 2002 Apr; 46(4):1032-7. PubMed ID: 11897586
[TBL] [Abstract][Full Text] [Related]
13. A prospective survey of Aspergillus spp. in respiratory tract samples: Species identification and susceptibility patterns.
Castro C; Galán-Sanchez F; Linares MJ; Tejero R; Ruiz M; Serrano ML; Rodríguez-Iglesias M; Martín-Mazuelos E;
Med Mycol; 2019 Jun; 57(4):412-420. PubMed ID: 30289467
[TBL] [Abstract][Full Text] [Related]
14. In vitro susceptibilities of Aspergillus spp. causing otomycosis to amphotericin B, voriconazole and itraconazole.
Kaya AD; Kiraz N
Mycoses; 2007 Nov; 50(6):447-50. PubMed ID: 17944704
[TBL] [Abstract][Full Text] [Related]
15. Time-Kill Kinetics and In Vitro Antifungal Susceptibility of Non-fumigatus Aspergillus Species Isolated from Patients with Ocular Mycoses.
Öz Y; Özdemir HG; Gökbolat E; Kiraz N; Ilkit M; Seyedmousavi S
Mycopathologia; 2016 Apr; 181(3-4):225-33. PubMed ID: 26612621
[TBL] [Abstract][Full Text] [Related]
16. Molecular Identification and In Vitro Antifungal Susceptibility of Aspergillus Isolates Recovered from Otomycosis Patients in Western China.
Zhang L; Wang X; Houbraken J; Mei H; Liao W; Hasimu H; Liu W; Deng S
Mycopathologia; 2020 Jun; 185(3):527-535. PubMed ID: 32346838
[TBL] [Abstract][Full Text] [Related]
17. Molecular identification of Aspergillus species collected for the Transplant-Associated Infection Surveillance Network.
Balajee SA; Kano R; Baddley JW; Moser SA; Marr KA; Alexander BD; Andes D; Kontoyiannis DP; Perrone G; Peterson S; Brandt ME; Pappas PG; Chiller T
J Clin Microbiol; 2009 Oct; 47(10):3138-41. PubMed ID: 19675215
[TBL] [Abstract][Full Text] [Related]
18. Wild-type MIC distributions and epidemiological cutoff values for the triazoles and six Aspergillus spp. for the CLSI broth microdilution method (M38-A2 document).
Espinel-Ingroff A; Diekema DJ; Fothergill A; Johnson E; Pelaez T; Pfaller MA; Rinaldi MG; Canton E; Turnidge J
J Clin Microbiol; 2010 Sep; 48(9):3251-7. PubMed ID: 20592159
[TBL] [Abstract][Full Text] [Related]
19. Species Distribution and In Vitro Azole Susceptibility of Aspergillus Section Nigri Isolates from Clinical and Environmental Settings.
Iatta R; Nuccio F; Immediato D; Mosca A; De Carlo C; Miragliotta G; Parisi A; Crescenzo G; Otranto D; Cafarchia C
J Clin Microbiol; 2016 Sep; 54(9):2365-72. PubMed ID: 27413191
[TBL] [Abstract][Full Text] [Related]
20. Species of Aspergillus section Aspergillus from clinical samples in the United States.
Siqueira JPZ; Sutton DA; Gené J; García D; Wiederhold N; Guarro J
Med Mycol; 2018 Jul; 56(5):541-550. PubMed ID: 29420803
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
